42C fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
iX Biopharma Ltd. engages in the provision of development, manufacture, and commercialization of therapies for the treatment of acute and breakthrough pain, and other health conditions. It operates through the Specialty Pharmaceutical and Nutraceutical segments. The Specialty Pharmaceutical segment develops, manufactures and sells pharmaceutical and nutraceutical products. The Nutraceutical segment offers nutraceutical products. The company was founded by Yip Hang Lee on May 8, 2004, and is headquartered in Singapore.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
42C does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company